Abstract
BackgroundPrevious studies reported that patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) after cardiac surgery were at a higher risk of postoperative mortality. However, the impact of AKI and CRRT on long-term mortality has not yet been identified. Therefore, we investigated whether postoperative AKI requiring CRRT was associated with one-year all-cause mortality after coronary artery bypass grafting (CABG).MethodsFor this population-based cohort study, we analyzed data from the National Health Insurance Service database in South Korea. The cohort included all adult patients diagnosed with ischemic heart disease who underwent isolated CABG between January 2012 and December 2017.ResultsA total of 15,115 patients were included in the analysis, and 214 patients (1.4%) required CRRT for AKI after CABG during hospitalization. They received CRRT at 3.1 ± 8.5 days after CABG, for 3.1 ± 7.8 days. On multivariable Cox regression, the risk of 1-year all-cause mortality in patients who underwent CRRT was 7.69-fold higher. Additionally, on multivariable Cox regression, the 30-day and 90-day mortality after CABG in patients who underwent CRRT were 18.20-fold and 20.21-fold higher than the normal value, respectively. Newly diagnosed chronic kidney disease (CKD) requiring renal replacement therapy (RRT) 1 year after CABG in patients who underwent CRRT was 2.50-fold higher. In the generalized log-linear Poisson model, the length of hospital stay (LOS) in patients who underwent CRRT was 5% longer.ConclusionsThis population-based cohort study showed that postoperative AKI requiring CRRT was associated with a higher 1-year all-cause mortality after CABG. Furthermore, it was associated with a higher rate of 30-day and 90-day mortality, longer LOS, and higher rate of CKD requiring RRT 1 year after CABG. Our results suggest that CRRT-associated AKI after CABG may be associated with an increased risk of mortality; hence, there should be interventions in these patients after hospital discharge.
Highlights
Previous studies reported that patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) after cardiac surgery were at a higher risk of postoperative mortality
The association between postoperative AKI requiring CRRT and various outcomes such as 30-day mortality, 90-day mortality, length of hospital stay (LOS), and newly diagnosed chronic kidney disease (CKD) requiring renal replacement therapy (RRT) after cardiac surgery has not been investigated in detail
The risk of 1-year all-cause mortality in patients who were exposed to CRRT was 7.69-fold higher (HR, 7.69; 95% confidence intervals (CIs): 6.54 to 9.05; P < 0.001) than that in the control group
Summary
Previous studies reported that patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) after cardiac surgery were at a higher risk of postoperative mortality. The incidence of AKI requiring CRRT after cardiac surgery is reported to be 1.0%–2.0% [14, 15], and patients with severe AKI requiring CRRT are reported to have higher postoperative mortality [15, 16]. A previous study reported in-hospital mortality as high as 43.5% in patients who required CRRT after cardiac surgery [17]. The association between postoperative AKI requiring CRRT and various outcomes such as 30-day mortality, 90-day mortality, length of hospital stay (LOS), and newly diagnosed chronic kidney disease (CKD) requiring renal replacement therapy (RRT) after cardiac surgery has not been investigated in detail
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.